Here’s a **complete, integrated medical reference note** on **Twin Pregnancy**, structured for professional and academic use — concise but *comprehensive* for exam, clinical, and practice reference. --- # 🩺 **Twin Pregnancy (Multiple Gestation)** --- ## **Definition** Twin pregnancy = presence of **two fetuses** in the uterus simultaneously. A type of **multiple gestation** (can also include triplets, etc.). --- ## **Classification** ### 1️⃣ **By Zygosity (Genetic Origin)** | Type | Description | Mechanism | | --------------------------- | ------------------------------------- | ---------------------------------------------------------- | | **Dizygotic (Fraternal)** | 2 separate ova fertilized by 2 sperms | → 2 embryos, 2 placentas (may fuse), 2 amnions, 2 chorions | | **Monozygotic (Identical)** | 1 ovum fertilized by 1 sperm divides | → genetically identical fetuses | ### 2️⃣ **By Chorionicity and Amnionicity (Most Clinically Important)** | Type | Time of Division | Chorion | Amnion | % | | ------------------------------------- | -------------------------- | ------- | ------ | -------------------------------------- | | **Dichorionic diamniotic (DCDA)** | ≤3 days post-fertilization | 2 | 2 | 30% (all dizygotic + some monozygotic) | | **Monochorionic diamniotic (MCDA)** | 4–8 days | 1 | 2 | 70% of monozygotic | | **Monochorionic monoamniotic (MCMA)** | 8–13 days | 1 | 1 | <1% | | **Conjoined twins** | >13 days | Shared | Shared | Rare | --- ## **Epidemiology** * Global incidence ≈ 1 in 80 pregnancies * DZ: ↑ with maternal age, multiparity, family history, ovulation induction (clomiphene, ART). * MZ: constant worldwide (~1/250). --- ## **Pathophysiology** * **Increased maternal and fetal demand**: expanded plasma volume, higher cardiac output. * **Placental overwork → complications** (anemia, preeclampsia, preterm labor). * **Monochorionic sharing → vascular anastomoses → TTTS, TAPS, TRAP**. --- ## **Risk Factors** * Advanced maternal age (>35 yrs) * Family history (maternal side) * African race * Ovulation induction (clomiphene, gonadotropins) * Assisted reproductive techniques (IVF) --- ## **Diagnosis** ### **Clinical** * Rapid uterine enlargement * Excessive weight gain * Multiple fetal poles/heart sounds * Polyhydramnios features ### **Investigations** | Test | Findings | | ------------------------------ | ------------------------------------------------------------ | | **Ultrasound (Gold standard)** | Number of fetuses, chorionicity, amnionicity, placental site | | **Serum β-hCG, AFP** | Higher than singleton | | **Hemoglobin, hematocrit** | Monitor for anemia | | **Cervical length** | Predict preterm labor risk | **Determination of Chorionicity (1st Trimester USG):** * **Lambda (twin peak) sign → DCDA** * **T-sign → MCDA** --- ## **Complications** ### **Maternal** * Hyperemesis gravidarum * Anemia * Preeclampsia, GDM * Preterm labor, PROM * Postpartum hemorrhage * Polyhydramnios ### **Fetal** * Miscarriage / IUFD * IUGR (especially monochorionic) * Congenital anomalies * TTTS, TAPS, TRAP * Cord accidents (in MCMA) * Prematurity * Discordant growth --- ## **Special Syndromes (Monochorionic Twins)** | Syndrome | Mechanism | Key Features | | -------------------------------------------- | ------------------------------------------------- | ------------------------------------------------------------------------------ | | **TTTS (Twin–Twin Transfusion Syndrome)** | Arteriovenous anastomosis → donor → recipient | Donor: growth-restricted, oligohydramnios; Recipient: polyhydramnios, overload | | **TAPS (Twin Anemia–Polycythemia Sequence)** | Small AV anastomoses | Anemia–polycythemia without fluid imbalance | | **TRAP (Twin Reversed Arterial Perfusion)** | One twin acardiac → perfused by other (pump twin) | Pump twin at high risk of failure | --- ## **Management** ### **Antenatal Care** * **Frequent visits:** every 2 weeks after 24 weeks * **Iron, folate supplementation:** increased requirement * **Ultrasound:** * DCDA → every 4 weeks * MCDA → every 2 weeks from 16–18 weeks * **Monitor for TTTS, growth discordance** * **Nutrition:** +300 kcal/day extra, +protein intake * **Bed rest in 3rd trimester** if symptomatic ### **Timing & Mode of Delivery** | Type | Timing | Mode | | --------- | -------------------------------------------------------------- | ---------------------------------------- | | DCDA | 37–38 weeks | Vaginal if 1st twin cephalic | | MCDA | 36–37 weeks | Vaginal possible | | MCMA | 32–34 weeks | **Cesarean** (risk of cord entanglement) | | TTTS/TRAP | Individualized (may need laser ablation / selective reduction) | | --- ## **Intrapartum Management** * Deliver in tertiary center with NICU * Continuous fetal monitoring * Twin 1 cephalic → vaginal allowed * Twin 2 non-cephalic → breech extraction or C-section * Active management of 3rd stage → prevent PPH * Uterotonics + controlled cord traction --- ## **Postpartum Care** * Monitor for **PPH, anemia** * Encourage **breastfeeding (adequate rest & nutrition)** * Contraceptive counselling --- ## **Drugs Commonly Used** | Drug | Indication | Mechanism | Dose | Adverse Effects | Notes | | ----------------------------------- | --------------------------- | ---------------------- | ----------------------------------------- | ------------------------------ | ------------------------------ | | **Iron + folate** | Anemia prevention | RBC synthesis | 100 mg elemental Fe + 0.5 mg folate daily | GI upset | Continue throughout pregnancy | | **Tocolytics (e.g., Nifedipine)** | Preterm labor | Ca²⁺ channel blocker | 10–20 mg q6h | Hypotension, flushing | Avoid if hypotensive | | **Corticosteroids (Betamethasone)** | Fetal lung maturity | Accelerates surfactant | 12 mg IM q24h × 2 doses | Hyperglycemia | <34 weeks gestation | | **Magnesium sulfate** | Neuroprotection / eclampsia | NMDA antagonist | 4 g IV bolus + 1 g/hr | Hyporeflexia, resp. depression | Monitor reflexes, urine output | --- ## **Investigations to Monitor** * Hb, BP, urine albumin * Fundal height, symphysiofundal growth * Ultrasound growth scans * Fetal Doppler * Non-stress test (NST) * Cervical length by TVS --- ## **Counselling Points** * High-risk pregnancy → tertiary center * Signs of preterm labor * Nutrition: iron-rich, protein, calcium * Rest and hydration * Fetal kick count monitoring * Avoid self-medication --- ## **Differential Diagnoses** * Hydatidiform mole * Polyhydramnios * Large-for-dates (macrosomia) * Uterine fibroids with pregnancy --- ## **Prognosis** * Maternal and perinatal morbidity and mortality **increased 3–4×** vs singleton * Better with early diagnosis, close monitoring, and delivery at tertiary care center --- ## **Tags** twin pregnancy, monochorionic, dichorionic, dizygotic, monozygotic, TTTS, TAPS, TRAP, twin complications, antenatal care, intrapartum management, preterm labor, obstetrics, high-risk pregnancy --- Would you like me to make **20 case-based MCQs** with explanations (and interactive HTML/CSS/JS file) on **Twin Pregnancy** next? Here are **20 high-yield case scenarios** on **Twin Pregnancy** — each with **clinical presentation**, **diagnosis**, and **management including Rx** — concise but comprehensive for academic and clinical use. --- ## 🩺 **Twin Pregnancy — 20 Case Scenarios with Management** --- ### **Case 1: Early Diagnosis** **Scenario:** A 28-year-old primigravida, 10 weeks gestation, presents for her first antenatal scan showing two gestational sacs with two yolk sacs and thick intervening membrane. **Diagnosis:** Dichorionic diamniotic (DCDA) twins. **Management:** * Routine antenatal care; visit every 4 weeks until 28 weeks, then every 2 weeks. * Iron + folate: 100 mg Fe + 0.5 mg folate daily. * USG every 4 weeks for growth. * Deliver at 37–38 weeks if no complications. --- ### **Case 2: Monochorionic Early Detection** **Scenario:** A 23-year-old at 12 weeks has two fetuses, a single placenta, and a thin dividing membrane (T-sign). **Diagnosis:** Monochorionic diamniotic (MCDA) twins. **Management:** * Scan every 2 weeks from 16–18 weeks for TTTS/TAPS. * Folic acid, iron, calcium supplementation. * Elective delivery at 36–37 weeks if uncomplicated. --- ### **Case 3: Rapid Uterine Growth** **Scenario:** A 30-year-old G2P1 at 22 weeks reports excessive abdominal distension. Fundal height 28 weeks; two fetal poles palpable. **Diagnosis:** Twin pregnancy with polyhydramnios suspicion. **Management:** * Confirm chorionicity on USG. * Monitor maternal BP, hemoglobin. * Evaluate for TTTS (if monochorionic). * If severe maternal distress → therapeutic amnioreduction. --- ### **Case 4: TTTS Stage I** **Scenario:** MCDA twins at 20 weeks; one sac has deep vertical pocket >8 cm, the other <2 cm; bladder visible in donor twin. **Diagnosis:** Stage I Twin-to-Twin Transfusion Syndrome (TTTS). **Management:** * Close surveillance every 1 week. * Fetal echo and Doppler. * Laser ablation if progression to stage II or higher. --- ### **Case 5: TTTS Stage III** **Scenario:** MCDA twins at 22 weeks; donor twin anhydramnios, absent bladder; recipient twin with polyhydramnios and cardiac strain. **Diagnosis:** TTTS (Quintero stage III). **Management:** * Fetoscopic laser ablation of vascular anastomoses. * Post-procedure follow-up every 2 weeks. * Corticosteroids at 28–30 weeks for lung maturity. --- ### **Case 6: Twin Anemia–Polycythemia Sequence (TAPS)** **Scenario:** MCDA twins at 28 weeks; Twin A shows MCA-PSV >1.5 MoM (anemia), Twin B <1.0 MoM (polycythemia); no fluid imbalance. **Diagnosis:** TAPS. **Management:** * Stage-based: * Mild → close Doppler surveillance. * Moderate–severe → intrauterine transfusion for anemic twin, partial exchange for polycythemic twin. * Delivery at 32–34 weeks. --- ### **Case 7: TRAP Sequence** **Scenario:** At 18 weeks, one twin without cardiac activity or head (acardiac twin), the other shows cardiomegaly. **Diagnosis:** Twin Reversed Arterial Perfusion (TRAP). **Management:** * Radiofrequency ablation or laser coagulation of acardiac twin’s cord. * Monitor “pump” twin for heart failure, hydrops. --- ### **Case 8: Discordant Growth** **Scenario:** MCDA twins; Twin A estimated 1.2 kg, Twin B 900 g at 30 weeks. Umbilical Doppler normal. **Diagnosis:** Mild growth discordance. **Management:** * Weekly Doppler and growth scan. * Optimize maternal nutrition and rest. * If discordance >25% or abnormal Doppler → consider delivery. --- ### **Case 9: Preterm Labor** **Scenario:** Twin pregnancy at 32 weeks presents with contractions, cervix 3 cm dilated. **Diagnosis:** Threatened preterm labor. **Management:** * **Betamethasone 12 mg IM q24h × 2 doses.** * **Tocolysis:** Nifedipine 20 mg PO, repeat q6h if stable. * **MgSO₄ 4 g IV bolus + 1 g/hr** for neuroprotection if <32 weeks. * Transfer to tertiary care unit. --- ### **Case 10: Preeclampsia** **Scenario:** DCDA twins at 34 weeks; BP 160/100 mmHg, proteinuria 3+. **Diagnosis:** Severe preeclampsia. **Management:** * **MgSO₄** (4 g IV + 1 g/hr). * **Antihypertensives:** Labetalol 100 mg TDS or Hydralazine 5–10 mg IV PRN. * Stabilize and deliver (induce or C-section). --- ### **Case 11: Anemia** **Scenario:** Twin pregnancy at 26 weeks; Hb 8.2 g/dL. **Diagnosis:** Iron-deficiency anemia of pregnancy. **Management:** * **Oral iron (100 mg Fe + 0.5 mg folate daily).** * If Hb <8 → IV iron sucrose. * Nutritional counseling: iron-rich diet. --- ### **Case 12: Gestational Diabetes** **Scenario:** Twin pregnancy, 30 weeks, fasting glucose 102 mg/dL, 2-hour OGTT 180 mg/dL. **Diagnosis:** GDM. **Management:** * Diet + exercise. * If uncontrolled → Insulin therapy. * Regular USG to assess growth, polyhydramnios. --- ### **Case 13: Monochorionic Monoamniotic Twins** **Scenario:** 28 weeks MCMA twins found on USG with cord entanglement. **Diagnosis:** Monoamniotic twin pregnancy. **Management:** * Hospitalize at 28–30 weeks. * Daily NST and Doppler. * **Elective C-section at 32–34 weeks.** --- ### **Case 14: One Twin Demise** **Scenario:** MCDA twins, one twin IUFD at 26 weeks. **Diagnosis:** Single fetal demise in monochorionic twins. **Management:** * Evaluate surviving twin by Doppler, MRI for brain injury. * Corticosteroids for lung maturity. * Deliver at 34–36 weeks unless distress develops. --- ### **Case 15: Twin Pregnancy with Polyhydramnios** **Scenario:** 32 weeks, rapid abdominal distension, dyspnea; AFI 35 cm. **Diagnosis:** Severe polyhydramnios in twin pregnancy. **Management:** * **Amnioreduction** under USG. * Monitor maternal respiration and contractions. * Consider TTTS or diabetes screening. --- ### **Case 16: Discordant Fetal Presentation** **Scenario:** Twin 1 cephalic, Twin 2 breech, 37 weeks. **Diagnosis:** DCDA twins with non-cephalic 2nd twin. **Management:** * Vaginal delivery allowed if Twin 1 cephalic and no contraindication. * Breech extraction of 2nd twin by experienced operator. * C-section if fetal distress or failed delivery. --- ### **Case 17: Postpartum Hemorrhage (PPH)** **Scenario:** After twin delivery, uterus boggy, heavy bleeding. **Diagnosis:** Uterine atony causing PPH. **Management:** * **Oxytocin 10 IU IV bolus + infusion 40 IU in 1L RL.** * Uterine massage. * If refractory: **Carboprost 250 µg IM q15–20min (max 8 doses)** or **Misoprostol 800 µg PR.** * Correct anemia, fluid resuscitation. --- ### **Case 18: Postpartum Care** **Scenario:** Twin mother exhausted, poor milk output. **Diagnosis:** Lactation insufficiency secondary to fatigue. **Management:** * Encourage frequent feeding/pumping. * Ensure 3–4 L fluid/day, calorie-dense diet. * Support groups, lactation consultant. * Iron + calcium supplementation. --- ### **Case 19: Late-Onset TTTS** **Scenario:** MCDA twins at 30 weeks with discordant growth and fluid difference. **Diagnosis:** Late TTTS. **Management:** * Stage-based approach; laser if indicated. * If ≥32 weeks → deliver after steroids. * Monitor Doppler and fetal well-being. --- ### **Case 20: Term DCDA Pregnancy** **Scenario:** 37-week DCDA twins, both cephalic, no complications. **Diagnosis:** Uncomplicated twin term pregnancy. **Management:** * Induce or allow spontaneous labor. * Continuous fetal monitoring. * Active management of 3rd stage (oxytocin). * Postpartum: monitor for anemia, PPH. --- ### **💊 Summary of Key Drug Doses** | Drug | Dose | Indication | | ----------------- | ------------------------------- | --------------------------- | | **Betamethasone** | 12 mg IM q24h × 2 | Fetal lung maturity | | **Nifedipine** | 20 mg PO q6h | Tocolysis | | **MgSO₄** | 4 g IV + 1 g/hr | Neuroprotection / eclampsia | | **Iron + Folate** | 100 mg Fe + 0.5 mg folate daily | Anemia prophylaxis | | **Labetalol** | 100 mg TDS | Hypertension | | **Oxytocin** | 10 IU IV + 40 IU in infusion | PPH prevention | --- Would you like me to now make this **20 case scenario set interactive** (searchable and filterable by condition or complication) in **HTML/CSS/JS** format — similar to your previous MCQ setup?